Order
176031-17-7
4-Morpholinecarboxamide,N-[3-[3-oxo-2-(phenylmethyl)pyrido[2,3-b]pyrazin-4(3H)-yl]phenyl]-
Order
175139-49-8
Pyrimidine,4-(1-ethylpropoxy)-2-methyl-5-(1-methylethyl)-6-(2,4,6-trimethylphenoxy)-
Order
168820-82-4
Guanidine, [2-benzofuranyl(5-bromo-2-methoxyphenyl)methyl]-,mono(4-methylbenzenesulfonate)
Order
175856-39-0
5-Thiazolecarboxylic acid,4,5-dihydro-2-[(2-methoxyphenyl)amino]-4-oxo-, ethyl ester
Order
176029-81-5
1,3-Benzodioxole-5-carboxamide,N-[3-[3-oxo-2-(phenylmethyl)pyrido[2,3-b]pyrazin-4(3H)-yl]phenyl]-
Order
168894-96-0
2-Thiophenecarboximidamide,N-[3-[2-(3,4-dihydro-2(1H)-isoquinolinyl)ethyl]phenyl]-, ethanedioate(1:2)
175856-39-0,175866-44-1,175073-71-9,175971-08-1,176029-81-5,176031-17-7 Supplier | KINGPHARM.GROUP
CMO CDMO service. KINGPHARM.GROUP supply 175856-39-0,175866-44-1,175073-71-9,175971-08-1,176029-81-5,176031-17-7 and related compounds.
176029-81-5
175856-39-0
175971-08-1
176031-17-7
175866-44-1
175073-71-9